This product is widely used to treat diabetic neuropathy. In vitro tests show that this product can reduce lipid oxidation in nerve tissue, may prevent protein glycosylation, inhibit aldose reductase, thereby preventing glucose or galactose from being converted into sorbitol, preventing diabetes, controlling blood sugar, and preventing neuropathy caused by high blood sugar. It is a strong antioxidant in both water-soluble and oil-soluble matrices. Its reduced form of dihydrolipoic acid can also play an antioxidant role, which can directly or indirectly promote the regeneration of vitamin C and vitamin E in the body. Studies have shown that it can increase the levels of glutathione and coenzyme Q10 in cells.

Anti-tumor drug. This product is a non-specific drug for the cell cycle, but it has a more obvious effect on the S phase, increasing the number of cells in the G1 phase and reducing the number of cells in the S phase and G2M phase. Its mechanism of action is to inhibit the initial stage of protein synthesis, inhibit the activity of DNA polymerase α, lead to a decrease in DNA synthesis, and severely inhibit protein synthesis. This product also has the effects of inducing cell differentiation, increasing cAMP content, and inhibiting glycoprotein synthesis.

Anti-tumor drug. This product is a non-specific drug for the cell cycle, but it has a more obvious effect on the S phase, increasing the number of cells in the G1 phase and reducing the number of cells in the S phase and G2M phase. Its mechanism of action is to inhibit the initial stage of protein synthesis, inhibit the activity of DNA polymerase α, lead to a decrease in DNA synthesis, and severely inhibit protein synthesis. This product also has the effects of inducing cell differentiation, increasing cAMP content, and inhibiting glycoprotein synthesis.

It can inhibit the synthesis of eukaryotic cell proteins, disaggregate polyribosomes, and interfere with the function of protein ribosomes. It also has an inhibitory effect on the synthesis of intracellular DNA. It has the strongest killing effect on G1 and G2 phase cells, but has a smaller effect on S phase cells. It has no cross-resistance with cytarabine, mercaptopurine, etc.

This product has the effects of dilating blood vessels and lowering blood lipids, and is significantly effective in lowering diastolic blood pressure.